NDC 0591-0395
Pentazocine and naloxone
Pentazocine Hydrochloride And Naloxone Hydrochloride
Pentazocine and naloxone is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Actavis Pharma, Inc.. The primary component is Pentazocine Hydrochloride; Naloxone Hydrochloride.
Product ID | 0591-0395_23c66a22-a657-442f-8ea3-1f8dcde4a37e |
NDC | 0591-0395 |
Product Type | Human Prescription Drug |
Proprietary Name | Pentazocine and naloxone |
Generic Name | Pentazocine Hydrochloride And Naloxone Hydrochloride |
Dosage Form | Tablet |
Route of Administration | ORAL |
Marketing Start Date | 1997-05-21 |
Marketing Category | ANDA / ANDA |
Application Number | ANDA074736 |
Labeler Name | Actavis Pharma, Inc. |
Substance Name | PENTAZOCINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE |
Active Ingredient Strength | 50 mg/1; mg/1 |
Pharm Classes | Competitive Opioid Antagonists [MoA],Partial Opioid Agonist/Antagonist [EPC],Partial Opioid Agonists [MoA],Opioid Antagonist [EPC],Opioid Antagonists [MoA] |
DEA Schedule | CIV |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |